Literature DB >> 24090571

Both LCCL-domains of human CRISPLD2 have high affinity for lipid A.

Viktor Vásárhelyi1, Mária Trexler2, László Patthy3.   

Abstract

The LCCL-domain is a recently defined protein module present in diverse extracellular multidomain proteins. Practically nothing is known about the molecular function of these domains; based on functional features of proteins harboring LCCL-domains it has been suggested that these domains might function as lipopolysaccharide-binding domains. Here we show that the two LCCL-domains of human CRISPLD2 protein, a lipopolysaccharide-binding serum protein involved in defense against endotoxin shock, have higher affinity for the lipid A, the toxic moiety of lipopolysaccharides than for ipopolysaccharide. Our observation that the LCCL-domains of CRISPLD2 are specific for the toxic lipid A moiety of the endotoxin suggests that it may block the interaction between endotoxins and the host endotoxin receptors without interfering with the development of antibacterial immunity against the polysaccharide moiety of LPS. We suggest that the anti-inflammatory function of CRISPLD2 protein may account for its role in various pathological and developmental processes.
Copyright © 2013 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  CRISPLD2; CRISPLD2 protein; CRISPLD2_LCCL1; CRISPLD2_LCCL1+2; CRISPLD2_LCCL2; Cysteine-Rich Secretory Protein LCCL Domain containing 2; Endotoxin; LA; LCCL-domain; LGL1; LPS; Lipid A; Lipopolysaccharide; NSCLP; SPR; late gestation lung protein 1; lipopolysaccharide; non-syndromic cleft lip and palate; protein containing the first LCCL domain of CRISPLD2; protein containing the first and second LCCL domains of CRISPLD2; protein containing the second LCCL domain of CRISPLD2; surface plasmon resonance

Mesh:

Substances:

Year:  2013        PMID: 24090571     DOI: 10.1016/j.biochi.2013.09.021

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  9 in total

1.  An analysis of glucocorticoid receptor-mediated gene expression in BEAS-2B human airway epithelial cells identifies distinct, ligand-directed, transcription profiles with implications for asthma therapeutics.

Authors:  T Joshi; M Johnson; R Newton; M Giembycz
Journal:  Br J Pharmacol       Date:  2015-01-08       Impact factor: 8.739

2.  Crispld2 is required for neural crest cell migration and cell viability during zebrafish craniofacial development.

Authors:  Eric C Swindell; Qiuping Yuan; Lorena E Maili; Bhavna Tandon; Daniel S Wagner; Jacqueline T Hecht
Journal:  Genesis       Date:  2015-09-05       Impact factor: 2.487

Review 3.  Understanding how long-acting β2 -adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids in asthma - an update.

Authors:  Robert Newton; Mark A Giembycz
Journal:  Br J Pharmacol       Date:  2016-11-09       Impact factor: 8.739

4.  The long-acting β2 -adrenoceptor agonist, indacaterol, enhances glucocorticoid receptor-mediated transcription in human airway epithelial cells in a gene- and agonist-dependent manner.

Authors:  T Joshi; M Johnson; R Newton; M A Giembycz
Journal:  Br J Pharmacol       Date:  2015-03-24       Impact factor: 8.739

5.  Relationships between Circulating Urea Concentrations and Endometrial Function in Postpartum Dairy Cows.

Authors:  Zhangrui Cheng; Chike F Oguejiofor; Theerawat Swangchan-Uthai; Susan Carr; D Claire Wathes
Journal:  Animals (Basel)       Date:  2015-08-14       Impact factor: 2.752

6.  CRISPLD2 is a target of progesterone receptor and its expression is decreased in women with endometriosis.

Authors:  Jung-Yoon Yoo; Heesung Shin; Tae Hoon Kim; Won-Seok Choi; Susan D Ferguson; Asgerally T Fazleabas; Steven L Young; Bruce A Lessey; Un-Hwan Ha; Jae-Wook Jeong
Journal:  PLoS One       Date:  2014-06-23       Impact factor: 3.240

Review 7.  Potential mechanisms to explain how LABAs and PDE4 inhibitors enhance the clinical efficacy of glucocorticoids in inflammatory lung diseases.

Authors:  Mark A Giembycz; Robert Newton
Journal:  F1000Prime Rep       Date:  2015-02-03

Review 8.  Plasmodium falciparum Secretome in Erythrocyte and Beyond.

Authors:  Rani Soni; Drista Sharma; Tarun K Bhatt
Journal:  Front Microbiol       Date:  2016-02-19       Impact factor: 5.640

9.  Identification of a rare COCH mutation by whole-exome sequencing : Implications for personalized therapeutic rehabilitation in an Austrian family with non-syndromic autosomal dominant late-onset hearing loss.

Authors:  Thomas Parzefall; Alexandra Frohne; Martin Koenighofer; Andreas Kirchnawy; Berthold Streubel; Christian Schoefer; Wolfgang Gstoettner; Klemens Frei; Trevor Lucas
Journal:  Wien Klin Wochenschr       Date:  2017-07-21       Impact factor: 1.704

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.